Back

Short and long-term mortality in patients with acute pulmonary embolism: focus on cancer-related disease.

13 May 2024 (09:00 - 09:45)
Organised by: Logo
Congress Presentation Part of: Myocardial disease - clinical 1 Pulmonary Embolism (PE) HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speakers

Photo
Doctor Fabiana Duarte

Hospital Divino Espirito Santo, Ponta Delgada (Portugal)

Photo
Doctor Ines Santos

Hospital Divino Espirito Santo, Ponta Delgada (Portugal)

7 More presentations in this session

Presentation thumbnail
Relationship between dynamics of cardiac sympathetic innervation, assessed with 123I-MIBG SPECT, exercise capacity and left ventricular reverse remodelling in dilated cardiomyopathy
Doctor E. Dziewiecka (Krakow, PL)
Abstract Slides Video
Presentation thumbnail
The genetic architecture of dilated cardiomyopathy in Hungary: analysis of 135 patients with a panel of 98 genes
Doctor H. Takacs (Szeged, HU)
Abstract Slides Video
Presentation thumbnail
Prevalence and predictors of normotensive cardiogenic shock in intermediate-high risk pulmonary embolism.
Doctor B. Lacerda Teixeira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Hyponatremia as a predictor of short-term mortality in patients with pulmonary embolism
Doctor J. Gouveia Fiuza (Viseu, PT)
Abstract Slides Video
Presentation thumbnail
PERFORM score: a predictive prognostic tool for anticipating the requirement for fibrinolysis in pulmonary embolism
Doctor M. Duarte Almeida (Viseu, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Myocardial disease - clinical 1

The Event

Event poster

Heart Failure 2024

13 May 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Baseline characteristics, management patterns and outcome in patients with pulmonary embolism and malignancy: Insights from a single-centre study
thumbnail
Congress Presentation
The efficacy and safety of thrombolytic therapy for acute pulmonary embolism in patients with active malignant disease
thumbnail
Congress Presentation
Clinical outcomes of half-dose extended anticoagulation in cancer-associated pulmonary thromboembolism: a real-world cohort study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources